Table 6.

Multivariate Analysis of Pretreatment and Postintervention Variables (N = 229)

EFS RR POS RR P
No Δ 11/13q  .481  .0004  No Δ 11/13q  .386  .0001 
β2M ≤4.0 mg/L  .534  .0006  Any second Tx  .200 .0002  
Any second Tx  .307  .001  Time to second Tx 1.008  .0005  
Time to second Tx  1.005  .03  Time to first CR  1.001  .02  
Any first CR    NA6-150 .17 β2M ≤4.0 mg/L  .609  .03  
Time to first CR   NA6-150 .42  Any first Tx    NA6-150 .06 
EFS RR POS RR P
No Δ 11/13q  .481  .0004  No Δ 11/13q  .386  .0001 
β2M ≤4.0 mg/L  .534  .0006  Any second Tx  .200 .0002  
Any second Tx  .307  .001  Time to second Tx 1.008  .0005  
Time to second Tx  1.005  .03  Time to first CR  1.001  .02  
Any first CR    NA6-150 .17 β2M ≤4.0 mg/L  .609  .03  
Time to first CR   NA6-150 .42  Any first Tx    NA6-150 .06 
F6-150

RR estimates are not calculated for variables excluded from the final model.

Abbreviation: RR, relative risk.

or Create an Account

Close Modal
Close Modal